Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Clinical trial NCT01366547 · COMPLETED

Trial details

NCT number: NCT01366547
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Infection, Human Immunodeficiency Virus

Start date: 2011-06-01
Primary completion: 2011-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.